2741.1000 -14.30 (-0.52%)
NSE Sep 19, 2025 15:31 PM
Volume: 85,057
 

2741.10
-0.52%
Sharekhan
steady operating performance with revenue growing by ~8% (driven by 5.4% volume growth). Strong expansion in EBIDTA margins and higher other income led to strong bottom-line growth. Horlicks continued to maintain its leadership in the Health Food Drinks (HFD) category with 44% market share. Premium products gaining good traction coupled with new product launches and improving penetration will be key revenue drivers going ahead. The integration of GSK Consumer and Hindustan Unilever (HUL) will take place by...
Number of FII/FPI investors increased from 340 to 390 in Jun 2025 qtr.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended